Education
About Us
Working with TipRanks
Follow Us
AB Science SA (FR:AB)
:AB
Standard of Care, Masitinib (4.5)
Alzheimer Disease
Phase III
Not Yet Recruiting
Masitinib in Patients With Mild to Moderate Alzheimer's Disease
Sep 29, 2022
―
Best Supportive Care, Masitinib 4.5 Mg/Kg/Day, Masitinib 6.0 Mg/Kg/Day
Mast Cell Activation Syndrome
Phase II
Unknown
Masitinib for the Treatment of Severe Mast Cell Activation Syndrome
Jul 02, 2022
―
Masitinib (4.5)
Progressive Multiple Sclerosis
Phase III
Recruiting
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
Jun 28, 2022
―
Azacitidine, Ab8939
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, In Relapse, Myelodysplastic Syndrome Acute Myeloid Leukemia
Phase I/II
Recruiting
AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Jan 12, 2022
―
14C-Ab1010
Healthy Volunteers
Early Phase I
Completed
Mass Balance Recovery, Metabolite Profile and Metabolite Identification of 14C-AB1010 in Healthy Male Subjects
Dec 27, 2021
―
Masitinib Mesylate
COVID19, Sars-Cov2 Infection, Coronavirus Disease 2019
Phase II
Unknown
Masitinib in Patients With Symptomatic Mild to Moderate COVID-19
Sep 16, 2021
―
Best Supportive Care, Masitinib, Isoquercetin
Covid-19, Sars-Cov 2, Coronavirus Disease 2019
Phase II
Unknown
Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19
Nov 09, 2020
―
Best Supportive Care, Masitinib
Indolent Systemic Mastocytosis
Phase III
Unknown
Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment
Apr 01, 2020
―
Masitinib
Asthma
Phase III
Completed
Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels
Dec 07, 2018
―
Gemcitabine, Masitinib
Locally Advanced Or Metastatic Pancreatic Cancer
Phase III
Completed
Masitinib Plus Gemcitabine in Pancreatic Cancer
Dec 04, 2018
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does AB Science SA (AB) have in its pipeline
AB is currently developing the following drugs: Standard of Care, Masitinib (4.5), Best Supportive Care, Masitinib 4.5 Mg/Kg/Day, Masitinib 6.0 Mg/Kg/Day, Masitinib (4.5). These drug candidates are in various stages of clinical development as the company works toward FDA approval.